OTCPK:DNAX

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

DNA Brands, Inc. provides energy drinks. It offers products in various flavors, such as cellular citrus zero sugar, cellular citrus, cryo berry, and molecular melon. More Details


Snowflake Analysis

Weak fundamentals or lack of information.


Similar Companies

Share Price & News

How has DNA Brands's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: DNAX's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

5.9%

DNAX

-0.1%

US Beverage

-0.4%

US Market


1 Year Return

10.4%

DNAX

1.8%

US Beverage

18.3%

US Market

Return vs Industry: DNAX exceeded the US Beverage industry which returned 1.8% over the past year.

Return vs Market: DNAX underperformed the US Market which returned 18.3% over the past year.


Shareholder returns

DNAXIndustryMarket
7 Day5.9%-0.1%-0.4%
30 Day-5.3%4.1%6.6%
90 Day-5.3%3.3%8.6%
1 Year10.4%10.4%4.5%1.8%21.0%18.3%
3 Year-99.5%-99.5%25.2%15.5%42.1%32.7%
5 Year-99.5%-99.5%46.7%28.5%85.6%64.7%

Price Volatility Vs. Market

How volatile is DNA Brands's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is DNA Brands undervalued compared to its fair value and its price relative to the market?


In this section, we usually try to help investors determine whether DNA Brands is trading at an attractive price based on the cash flow it is expected to produce in the future. But as DNA Brands has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.


Next Steps

  • Take a look at our analysis of DNAX's management and see if the CEO's compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don't know where to start, we recommend reading through DNA Brands regulatory filings here.
  • Explore potentially undervalued companies in the Food, Beverage & Tobacco industry.

Future Growth

How is DNA Brands forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

12.4%

Forecasted Food, Beverage & Tobacco industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as DNA Brands has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has DNA Brands performed over the past 5 years?

46.0%

Last years earnings growth


Earnings and Revenue History

Quality Earnings: DNAX is currently unprofitable.

Growing Profit Margin: DNAX is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if DNAX's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: Unable to compare DNAX's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: DNAX is unprofitable, making it difficult to compare its past year earnings growth to the Beverage industry (17.5%).


Return on Equity

High ROE: DNAX's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Next Steps

Financial Health

How is DNA Brands's financial position?


Financial Position Analysis

Short Term Liabilities: DNAX has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Long Term Liabilities: DNAX has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Debt to Equity History and Analysis

Debt Level: DNAX has negative shareholder equity, which is a more serious situation than a high debt level.

Reducing Debt: DNAX's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Insufficient data to determine if DNAX has enough cash runway based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if DNAX has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Next Steps

Dividend

What is DNA Brands's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate DNAX's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate DNAX's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if DNAX's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if DNAX's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of DNAX's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?


CEO

Adrian Mckenzie

no data

Tenure

Mr. Adrian P. McKenzie has been the Chief Executive Officer and Chairman of the Board at American Leisure Holdings, Inc. since November 1, 2018. He serves as Chief Executive Officer of DNA Brands, Inc. Mr. ...


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

DNA Brands, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: DNA Brands, Inc.
  • Ticker: DNAX
  • Exchange: OTCPK
  • Founded:
  • Industry: Soft Drinks
  • Sector: Food, Beverage & Tobacco
  • Market Cap: US$264.683k
  • Shares outstanding: 147.05m
  • Website: https://www.dnabrandsinc.com

Number of Employees


Location

  • DNA Brands, Inc.
  • 6245 N. Federal Highway
  • Suite 504
  • Fort Lauderdale
  • Florida
  • 33308
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
DNAXOTCPK (Pink Sheets LLC)YesCommon StockUSUSDJul 2010

Biography

DNA Brands, Inc. provides energy drinks. It offers products in various flavors, such as cellular citrus zero sugar, cellular citrus, cryo berry, and molecular melon. The company markets its products for re ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/10/24 23:53
End of Day Share Price2020/10/23 00:00
Earnings2019/09/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.